Zevin Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-1,805
Closed -$200K – 88
2022
Q1
$200K Buy
+1,805
New +$191K 0.04% 87
2021
Q4
– Sell
-1,882
Closed -$236K – 98
2021
Q3
$236K Buy
1,882
+106
+6% +$13.7K 0.05% 90
2021
Q2
$220K Hold
1,776
– – 0.04% 96
2021
Q1
$210K Hold
1,776
– – 0.05% 86
2020
Q4
$208K Buy
+1,776
New +$196K 0.05% 86
2020
Q1
– Sell
-1,858
Closed -$211K – 88
2019
Q4
$211K Hold
1,858
– – 0.06% 86
2019
Q3
$202K Buy
+1,858
New +$194K 0.07% 90

Other funds holding MDT

Zevin Asset Management's MDT Position: Q2 2022 in Review

Zevin Asset Management sold out of Medtronic (MDT) in Q2 2022, closing a stake of 1,805 shares — an estimated $200K sold.

Zevin Asset Management first reported a position in MDT in Q3 2019 and held it in 7 quarters. The position peaked at $236K in Q3 2021. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Zevin Asset Management reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Zevin Asset Management sold 1,805 Medtronic shares in Q2 2022, an estimated $200K.
  • Zevin Asset Management first reported a position in Medtronic in Q3 2019 and held it in 7 quarters.
  • Zevin Asset Management's Medtronic position peaked at $236K in Q3 2021.
  • 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Zevin Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.